Effect of length of controlled ovarian hyperstimulation using a gonadotropin-releasing hormone antagonist on in vitro fertilization pregnancy rates.
GD Royster, MG Retzloff, RD Robinson… - The Journal of …, 2012 - europepmc.org
Objective To compare pregnancy outcomes between shorter and longer in vitro fertilization
(IVF) or intracytoplasmic sperm injection (ICSI) cycles using GnRH antagonist protocol …
(IVF) or intracytoplasmic sperm injection (ICSI) cycles using GnRH antagonist protocol …
Prolonging GnRH-agonist to achieve ovarian suppression does not compromise the results of a long protocol
L Dessolle, D Ferrier, A Colombel, T Fréour… - European Journal of …, 2011 - Elsevier
OBJECTIVES: In the long gonadotropin-releasing hormone agonist (GnRHa) protocols,
stimulation is delayed until complete pituitary–ovarian suppression has been achieved …
stimulation is delayed until complete pituitary–ovarian suppression has been achieved …
[HTML][HTML] Endometrial thickness affects the outcome of in vitro fertilization and embryo transfer in normal responders after GnRH antagonist administration
Y Wu, X Gao, X Lu, J Xi, S Jiang, Y Sun, X Xi - Reproductive Biology and …, 2014 - Springer
Background The goal of this study was to assess the association between endometrial
thickness on the chorionic gonadotropin (hCG) day and in vitro fertilization and embryo …
thickness on the chorionic gonadotropin (hCG) day and in vitro fertilization and embryo …
[HTML][HTML] Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome
CA Benadiva, O Davis, I Kligman, M Moomjy, HC Liu… - Fertility and …, 1997 - Elsevier
Objective: To evaluate the outcomes of IVF and the incidence of ovarian hyperstimulation
syndrome (OHSS) after discontinuing gonadotropin therapy in patients at risk of developing …
syndrome (OHSS) after discontinuing gonadotropin therapy in patients at risk of developing …
[HTML][HTML] Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk …
LL Engmann, BS Maslow, LA Kaye, DW Griffin… - Journal of Ovarian …, 2019 - Springer
Background Ovarian hyperstimulation syndrome remains a serious complication during in
vitro fertilization cycles if high dose human chorionic gonadotropin (hCG) is used to trigger …
vitro fertilization cycles if high dose human chorionic gonadotropin (hCG) is used to trigger …
[HTML][HTML] Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in …
R Orvieto, J Kruchkovich, J Rabinson, E Zohav… - Fertility and sterility, 2008 - Elsevier
To evaluate the appropriate controlled ovarian hyperstimulation (COH) protocol in poor
responders, we compared the stimulation characteristics of 21 cycles, which included the …
responders, we compared the stimulation characteristics of 21 cycles, which included the …
GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies …
Abstract STUDY QUESTION Does a GnRH agonist (GnRHa) trigger followed by a bolus of
1.500 IU hCG in a group of patients at risk of ovarian hyperstimulation syndrome (OHSS) …
1.500 IU hCG in a group of patients at risk of ovarian hyperstimulation syndrome (OHSS) …
Gonadotropin-releasing hormone (GnRH)-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVF
SJ Fasouliotis, N Laufer, S Sabbagh-Ehrlich… - Journal of assisted …, 2003 - Springer
Purpose: The objective of this study was to compare the efficacy of GnRH-antagonists to
GnRH-agonists in ovarian stimulation of poor responders undergoing IVF. Methods …
GnRH-agonists in ovarian stimulation of poor responders undergoing IVF. Methods …
Substituting HCG with GnRH agonist to trigger final follicular maturation–a retrospective comparison of three different ovarian stimulation protocols
R Orvieto, J Rabinson, S Meltzer, E Zohav… - Reproductive …, 2006 - Elsevier
The study retrospectively evaluated the influence of triggering final oocyte maturation with
gonadotrophin-releasing hormone (GnRH) agonist on the outcome of IVF cycles. Four …
gonadotrophin-releasing hormone (GnRH) agonist on the outcome of IVF cycles. Four …
Final oocyte maturation with two different GnRH agonists in antagonist co-treated cycles at risk of ovarian hyperstimulation syndrome
Abstract Triptorelin 0.2 mg and leuprolide 1 mg subcutaneous injections for triggering final
follicular maturation were compared in patients with a high risk for ovarian hyperstimulation …
follicular maturation were compared in patients with a high risk for ovarian hyperstimulation …